ACTR-88. A PHASE II STUDY OF THE EFFICACY OF HYPOFRACTIONATED RADIATION THERAPY WITH BEVACIZUMAB AND TEMOZOLOMIDE FOLLOWED BY MAINTENANCE TEMOZOLOMIDE AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMAS

BACKGROUND: Patients with recurrent high grade glioma (rHGG) have a poor prognosis with limited treatment options, especially those refractory to bevacizumab. A phase II multi-center trial was performed to determine the overall survival (OS) of hypofractioned radiation with concurrent bevacizumab (B...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Dixit, Karan, Kumthekar, Priya, Kruser, Timothy, Sachdev, Sean, Kalapurakal, John A, Gondi, Vinai, Grimm, Sean, Nicholas, Martin, Lukas, Rimas V, Chmura, Steven J, Mehta, Minesh P, Raizer, Jeffrey
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692374/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.073
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi